| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 43,195 | 40,652 | 21,605 | 46,695 | | Cost of Revenue | 39,196 | 28,630 | 16,859 | (24,041) | | | Gross Profit | 3,999 | 12,022 | 4,746 | 70,736 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 59,333 | 17,602 | 18,958 | 61,636 | | Non Recurring | (31,781) | 64,651 | 1,536 | 55,748 | | Others | 4,003 | 4,307 | 4,055 | 4,039 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (27,556) | (74,538) | (19,803) | (50,687) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,291 | 1,041 | 1,278 | 2,000 | | Earnings Before Interest And Taxes | (26,265) | (73,497) | (18,525) | (48,687) | | Interest Expense | 65 | 139 | 128 | 38 | | Income Before Tax | (26,330) | (73,636) | (18,653) | (48,725) | | Income Tax Expense | (11,906) | (28,406) | (6,978) | (21,431) | | Minority Interest | 817 | (102) | 102 | 271 | | | | Net Income From Continuing Ops | (14,490) | (45,377) | (11,543) | (27,093) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (154) | (828) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (13,673) | (45,377) | (11,697) | (27,921) | | Preferred Stock And Other Adjustments | (757) | 757 |
-
|
-
| | | Net Income Applicable To Common Shares | ($14,430) | ($44,620) | ($11,697) | ($27,921) |
|
0.22% Nasdaq 
Income Statement
